Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis+2New York Stock Exchange+2
24 December 2025
UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

NEW YORK — December 24, 2025 — UiPath Inc. is having a headline-grabbing Christmas Eve session, with shares climbing sharply after S&P Dow Jones Indices selected UiPath for inclusion in the S&P MidCap 400. In late-morning U.S. trading, PATH hovered around $17.25, up roughly 8% on the day, after opening higher and trading between roughly $16.70 and $17.36. StockAnalysis
24 December 2025
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy. By late morning, shares were trading around $26.37—up roughly 21% versus the prior close—after swinging between about $21.30 and $27.05 on the day, with volume above 2.2 million shares.
Apple Stock (AAPL) Today: Price Near $274 as Brazil App Store Deal, Italy Antitrust Fine, and “Siri 2.0” Forecasts Define the 2026 Outlook

Apple Stock (AAPL) Today: Price Near $274 as Brazil App Store Deal, Italy Antitrust Fine, and “Siri 2.0” Forecasts Define the 2026 Outlook

Apple Inc. ended the Christmas Eve session in the spotlight for reasons that go well beyond day-to-day price action: regulators are tightening the screws on the App Store worldwide, courts are reshaping how app marketplaces can be policed, and Wall Street is increasingly treating Apple’s 2026 story as an “AI delivery” story—with Siri at the center of the plot.
24 December 2025
Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

December 24, 2025 — Rocket Lab Corporation stock is spending Christmas Eve doing what overheated momentum names often do: pausing and digesting. After a blistering December rally fueled by defense-contract news and a record-setting launch cadence, RKLB shares traded in the mid-$70s in the shortened U.S. session, slipping modestly as investors weigh how much of 2026’s growth is already priced in. MarketBeat+1
Denison Mines Stock (DNN, DML) News and Forecast on Dec. 24, 2025: Wheeler River Permitting, Skyharbour JV, and What Analysts Are Watching

Denison Mines Stock (DNN, DML) News and Forecast on Dec. 24, 2025: Wheeler River Permitting, Skyharbour JV, and What Analysts Are Watching

Denison Mines Corp. is heading into year-end with a familiar uranium-stock cocktail: a buoyant sector narrative, a tight fuel market, and one very specific company catalyst that keeps dominating the investment conversation—regulatory progress at the Wheeler River Project in Saskatchewan’s Athabasca Basin.
24 December 2025
Warner Bros. Discovery (WBD) Stock Today: Takeover Bids, Netflix Deal Financing, and What Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery (WBD) Stock Today: Takeover Bids, Netflix Deal Financing, and What Wall Street Forecasts on Dec. 24, 2025

December 24, 2025 — Warner Bros. Discovery, Inc. is trading in takeover territory on Christmas Eve, with the stock hovering around $29 and repeatedly pulled toward the headline $30-per-share hostile bid from Paramount Skydance. As of the latest available pricing, WBD shares were near $29.14, effectively pricing in a live merger-arbitrage chess match: the market is treating the Paramount offer as a real anchor, while also respecting the signed Netflix agreement and the regulatory, timing, and litigation risks still hanging over both paths.
Doomed SpaceX Starlink Satellite 35956 Photographed From Orbit After In‑Space Anomaly Spreads Debris

Doomed SpaceX Starlink Satellite 35956 Photographed From Orbit After In‑Space Anomaly Spreads Debris

Dec. 24, 2025 — A rare, close-up orbital photograph has provided a clearer look at a SpaceX Starlink satellite that suffered an in-space anomaly and is now tumbling toward reentry, while a growing debris field underscores how quickly low Earth orbit can become more complicated — and potentially more dangerous — as megaconstellations expand. Space+2Reuters+2
24 December 2025
Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla, Inc. is heading into the Christmas Eve session with its stock price hovering just below a psychologically important threshold: $500. That near-round-number “gravity” isn’t just trader superstition—it’s where valuation debates, delivery forecasts, and autonomy optimism collide for one of the market’s most narrative-driven mega-caps.
Intel Stock Slides as Nvidia Pauses 18A Testing; Nike Jumps on Tim Cook Buy and Dynavax Soars on Sanofi Deal

Intel Stock Slides as Nvidia Pauses 18A Testing; Nike Jumps on Tim Cook Buy and Dynavax Soars on Sanofi Deal

U.S. stocks were largely flat in thin, holiday-shortened trading on Wednesday, December 24, 2025, with investors watching whether the market can extend a year-end “Santa Claus rally” even as headlines moved individual names sharply. The S&P 500 hovered near its all-time highs after a record close the prior session, while standout moves centered on three widely followed companies: Intel, Nike, and Dynavax Technologies. Reuters
1 405 406 407 408 409 609
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.